360 related articles for article (PubMed ID: 22858556)
1. Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: which key messages in light of a new immunization program?
Morin A; Lemaître T; Farrands A; Carrier N; Gagneur A
Vaccine; 2012 Sep; 30(41):5921-7. PubMed ID: 22858556
[TBL] [Abstract][Full Text] [Related]
2. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.
Buttery JP; Lambert SB; Grimwood K; Nissen MD; Field EJ; Macartney KK; Akikusa JD; Kelly JJ; Kirkwood CD
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S25-9. PubMed ID: 21183837
[TBL] [Abstract][Full Text] [Related]
3. Canadian paediatricians' opinions on rotavirus vaccination.
Dubé E; Gilca V; Sauvageau C; Bradet R; Bettinger JA; Boulianne N; Boucher FD; McNeil S; Gemmill I; Lavoie F
Vaccine; 2011 Apr; 29(17):3177-82. PubMed ID: 21376118
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.
Mast TC; Khawaja S; Espinoza F; Paniagua M; Del Carmen LP; Cardellino A; Sánchez E
Pediatr Infect Dis J; 2011 Nov; 30(11):e209-15. PubMed ID: 21768920
[TBL] [Abstract][Full Text] [Related]
5. Rotavirus vaccines in Belgium: policy and impact.
Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
[TBL] [Abstract][Full Text] [Related]
6. Update on Rotarix: an oral human rotavirus vaccine.
O'Ryan M; Linhares AC
Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program.
MacDougall DM; Halperin BA; Langley JM; MacKinnon-Cameron D; Li L; Halperin SA;
Vaccine; 2016 Jan; 34(5):687-695. PubMed ID: 26458809
[TBL] [Abstract][Full Text] [Related]
8. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
[TBL] [Abstract][Full Text] [Related]
9. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
[TBL] [Abstract][Full Text] [Related]
11. Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.
Amador JJ; Vasquez J; Orozco M; Pedreira C; Malespin O; De Oliveira LH; Tate J; Parashar U; Patel M
Int J Infect Dis; 2010 Jul; 14(7):e592-5. PubMed ID: 20022778
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the oral pentavalent rotavirus vaccine in Mali.
Sow SO; Tapia M; Haidara FC; Ciarlet M; Diallo F; Kodio M; Doumbia M; Dembélé RD; Traoré O; Onwuchekwa UU; Lewis KD; Victor JC; Steele AD; Neuzil KM; Kotloff KL; Levine MM
Vaccine; 2012 Apr; 30 Suppl 1():A71-8. PubMed ID: 22520140
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
[TBL] [Abstract][Full Text] [Related]
14. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.
Paulke-Korinek M; Rendi-Wagner P; Kundi M; Kronik R; Kollaritsch H
Pediatr Infect Dis J; 2010 Apr; 29(4):319-23. PubMed ID: 19935446
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.
Atkins KE; Shim E; Carroll S; Quilici S; Galvani AP
Vaccine; 2012 Nov; 30(48):6766-76. PubMed ID: 23000223
[TBL] [Abstract][Full Text] [Related]
16. The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents.
Eberly MD; Gorman GH; Eide MB; Olsen CH; Rajnik M
Vaccine; 2011 Jan; 29(4):650-9. PubMed ID: 21129394
[TBL] [Abstract][Full Text] [Related]
17. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
[TBL] [Abstract][Full Text] [Related]
18. The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.
Muhsen K; Chodick G; Goren S; Shalev V; Cohen D
Vaccine; 2010 Dec; 29(1):91-4. PubMed ID: 20969927
[TBL] [Abstract][Full Text] [Related]
19. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants.
Vesikari T; Prymula R; Schuster V; Tejedor JC; Cohen R; Bouckenooghe A; Damaso S; Han HH
Pediatr Infect Dis J; 2012 May; 31(5):509-13. PubMed ID: 22228235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
